News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dekker Martin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Dekker Martin (See Remarks) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.8264, valued at
$41.3k
|
|
| 02/14/2023 |
4
| Dekker Martin (VP OF ENGINEERING & MANUFACTUR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.52, valued at
$76k
|
|
| 12/13/2022 |
4
| Dekker Martin (VP OF ENGINEERING & MANUFACTUR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,834 shares
@ $0.9301, valued at
$7.3k
Exercised 25,500 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Dekker Martin (VP OF ENGINEERING & MANUFACTUR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 51,000 restricted stock units
@ $0 |
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Dekker Martin (VP of Engineering & Manuf) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 175,500 options to buy
@ $0.5, valued at
$87.8k
|
|
| 01/04/2019 |
4
| Dekker Martin (VP of Engineering & Manuf) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $0.88, valued at
$11k
|
|
| 11/23/2018 |
4
| Dekker Martin (VP of Engineering & Manuf) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 137,500 options to buy
@ $0.91, valued at
$125.1k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2018 |
4
| Dekker Martin (VP of Engineering & Manuf) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,473 shares
@ $2.37, valued at
$17.7k
|
|
| 01/17/2018 |
4
| Dekker Martin (VP of Engineering & Manuf) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,675 shares
@ $0
Granted 80,000 options to buy
@ $2.03, valued at
$162.4k
|
|
| 01/08/2018 |
4
| Dekker Martin (VP of Engineering & Manuf) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 24,284 shares
@ $2.49, valued at
$60.5k
|
|
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2016 |
4
| Dekker Martin (VP of Device Engineering) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 13,333 shares
@ $1.38, valued at
$18.4k
|
|
|
|